Inclusion Criteria:
  -  Men and women age 65 years or older
  -  Current PD diagnosis with symptoms severity at Hoehn & Yahr (H&Y) stage 1-4 based on an expert assessment (movement disorders neurologist report or telemedicine evaluation)
  -  Willing and able to continue in follow-up for at least 2 years
  -  Willing and able to provide informed consent
Exclusion Criteria:
  -  History of hip fracture
  -  Any use of a bisphosphonate drug within the last 12 months
  -  Use of any other osteoporosis treatment (such as SERMs and denosumab) within the last 6 months     
  -  Tooth extraction or invasive dental procedures within the past 30 days or planned/scheduled extraction/procedure in the next 12 months
  -  Non-ambulatory, i.e., unable to walk without assistance of another person.
  -  Undergoing kidney dialysis
  -  A diagnosis of multiple myeloma or Paget's disease
  -  Unable to speak or read English sufficiently to complete informed consent
  -  Any other criteria, which would make the patient unsuitable to participate in this study as determined by the study staff (e.g., an uncontrolled drug and/or alcohol addiction)
